Home Special Topics Technology Offerings Content

Improving Bioavailability

next article

21.01.2008

The amidine group is an essential component of many pharmacologically active agents. However, in general pharmaceutical compositions with one or more amidine functions are almost inactive if given orally and must therefore be administered by injection. The present invention consists in a modification of at least one of the amidine functions of a pharmacological agent, resulting in its effective resorption via oral administration, followed by its conversion back into the original active form, the amidine, by the body’s own enzymes (prodrug principle).

Further Information: PDF

Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937

Contact
Dr. Alexandra Baumgartner

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

info@technologieallianz.de | Source: TechnologieAllianz e.V.
Further information: www.technologieallianz.de/angebote.php?sort=sag&id=1190&lang=en
www.technologieallianz.de

next article